FASENRA sol inj 30 mg/ml ser pré 1 ml
7680665820019
CH-66582
R03DX10
03.04.5.
Reimbursement limitations:
FASENRA
À la suite de la garantie de prise en charge par l’assureur maladie après consultation …
1 / 3
google
Details
- Product number
- 6658201
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- benralizumabum 30 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Fasenra 30 mg /1 ml, Injektionslösung in einer Fertigspritze
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
30.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 2538.90
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/08/2018
Authorization holder
AstraZeneca AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 66582
- Drug name
- Fasenra, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- R03DX10
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 08/06/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 03.04.5.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FASENRA sol inj 30 mg/ml ser pré 1 ml
- Description (DE)
- FASENRA Inj Lös 30 mg/ml Fertspr 1 ml
- Market launch
- 08/06/2018
- Narcotic (BTM)
- No